APO Research
Talk to an analyst

APO RESEARCH · REPORT

mRNA Raw Enzyme

mRNA raw enzymes are key enzymes used in the synthesis of mRNA. These enzymes catalyze the synthesis of RNA from a DNA template in vitro or play roles in mRNA modification and processing.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

mRNA raw enzymes are key enzymes used in the synthesis of mRNA. These enzymes catalyze the synthesis of RNA from a DNA template in vitro or play roles in mRNA modification and processing.

Selected research

Market Analysis & Forecast

Global mRNA Raw Enzyme Market Analysis and Forecast 2026-2032

21 December 2025204 pages

Choose your research edition.

Industry ResearchmRNA Raw Enzyme Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal mRNA Raw Enzyme Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal mRNA Raw Enzyme Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal mRNA Raw Enzyme Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal mRNA Raw Enzyme Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

mRNA raw enzymes are key enzymes used in the synthesis of mRNA. These enzymes catalyze the synthesis of RNA from a DNA template in vitro or play roles in mRNA modification and processing.

The global mRNA Raw Enzyme market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for mRNA Raw Enzyme is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Europe market for mRNA Raw Enzyme is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Asia-Pacific market for mRNA Raw Enzyme is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for mRNA Raw Enzyme is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of mRNA Raw Enzyme include Thermo Fisher, NEB, Merck, Aldevron, Roche CustomBiotech, Takara Bio Inc., Qiagen N.V., Promega and Novoprotein, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for mRNA Raw Enzyme, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of mRNA Raw Enzyme, also provides the revenue of main regions and countries. Of the upcoming market potential for mRNA Raw Enzyme, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the mRNA Raw Enzyme revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global mRNA Raw Enzyme market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for mRNA Raw Enzyme revenue, projected growth trends, production technology, application and end-user industry.

mRNA Raw Enzyme Segment by Company

Thermo Fisher

NEB

Merck

Aldevron

Roche CustomBiotech

Takara Bio Inc.

Qiagen N.V.

Promega

Novoprotein

Alphazyme

LGC Biosearch Technologies

Jena Bioscience

Yeasen Biotechnology

Hongene Biotech

Enzo Biochem

Spindle (Applied DNA Sciences)

Vazyme

mRNA Raw Enzyme Segment by Type

Restriction Enzyme

RNA Polymerase

Capping Enzyme

Inorganic Pyrophosphatase

RNase Inhibitor

2'-O-Methyltransferase

Poly(A) Polymerase

DNase I

mRNA Raw Enzyme Segment by Application

Biopharmaceutical Companies

Academic and Research Institutes

mRNA Raw Enzyme Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global mRNA Raw Enzyme market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of mRNA Raw Enzyme and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of mRNA Raw Enzyme.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of mRNA Raw Enzyme in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of mRNA Raw Enzyme company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, mRNA Raw Enzyme revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global mRNA Raw Enzyme Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Restriction Enzyme Major Player Table 3. RNA Polymerase Major Player Table 4. Capping Enzyme Major Player Table 5. Inorganic Pyrophosphatase Major Player Table 6. RNase Inhibitor Major Player Table 7. 2'-O-Methyltransferase Major Player Table 8. Poly(A) Polymerase Major Player Table 9. DNase I Major Player Table 10. Global mRNA Raw Enzyme Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 11. Biopharmaceutical Companies Major Player Table 12. Academic and Research Institutes Major Player Table 13. mRNA Raw Enzyme Industry Trends Table 14. mRNA Raw Enzyme Industry Drivers Table 15. mRNA Raw Enzyme Industry Opportunities and Challenges Table 16. mRNA Raw Enzyme Industry Restraints Table 17. Global mRNA Raw Enzyme Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global mRNA Raw Enzyme Market Size by Region (2021-2026) & (US$ Million) Table 19. Global mRNA Raw Enzyme Market Share by Region (2021-2026) Table 20. Global mRNA Raw Enzyme Market Size by Region (2027-2032) & (US$ Million) Table 21. Global mRNA Raw Enzyme Market Share by Region (2027-2032) Table 22. Global mRNA Raw Enzyme Revenue by Players (US$ Million) & (2021-2026) Table 23. Global mRNA Raw Enzyme Revenue Market Share by Players (2021-2026) Table 24. Global mRNA Raw Enzyme Key Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global mRNA Raw Enzyme Key Players Headquarters & Area Served Table 26. Global mRNA Raw Enzyme Players, Product Type & Application Table 27. Global mRNA Raw Enzyme Players Establishment Date Table 28. Global Players Market Concentration Ratio (CR5 and HHI) Table 29. Global mRNA Raw Enzyme by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 30. Global mRNA Raw Enzyme Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global mRNA Raw Enzyme Revenue by Type (2021-2026) & (US$ Million) Table 32. Global mRNA Raw Enzyme Revenue by Type (2027-2032) & (US$ Million) Table 33. Global mRNA Raw Enzyme Revenue Market Share by Type (2021-2026) Table 34. Global mRNA Raw Enzyme Revenue Market Share by Type (2027-2032) Table 35. Global mRNA Raw Enzyme Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global mRNA Raw Enzyme Revenue by Application (2021-2026) & (US$ Million) Table 37. Global mRNA Raw Enzyme Revenue by Application (2027-2032) & (US$ Million) Table 38. Global mRNA Raw Enzyme Revenue Market Share by Application (2021-2026) Table 39. Global mRNA Raw Enzyme Revenue Market Share by Application (2027-2032) Table 40. Thermo Fisher Company Information Table 41. Thermo Fisher Business Overview Table 42. Thermo Fisher mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Thermo Fisher mRNA Raw Enzyme Product Portfolio Table 44. Thermo Fisher Recent Development Table 45. NEB Company Information Table 46. NEB Business Overview Table 47. NEB mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. NEB mRNA Raw Enzyme Product Portfolio Table 49. NEB Recent Development Table 50. Merck Company Information Table 51. Merck Business Overview Table 52. Merck mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Merck mRNA Raw Enzyme Product Portfolio Table 54. Merck Recent Development Table 55. Aldevron Company Information Table 56. Aldevron Business Overview Table 57. Aldevron mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Aldevron mRNA Raw Enzyme Product Portfolio Table 59. Aldevron Recent Development Table 60. Roche CustomBiotech Company Information Table 61. Roche CustomBiotech Business Overview Table 62. Roche CustomBiotech mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Roche CustomBiotech mRNA Raw Enzyme Product Portfolio Table 64. Roche CustomBiotech Recent Development Table 65. Takara Bio Inc. Company Information Table 66. Takara Bio Inc. Business Overview Table 67. Takara Bio Inc. mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Takara Bio Inc. mRNA Raw Enzyme Product Portfolio Table 69. Takara Bio Inc. Recent Development Table 70. Qiagen N.V. Company Information Table 71. Qiagen N.V. Business Overview Table 72. Qiagen N.V. mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Qiagen N.V. mRNA Raw Enzyme Product Portfolio Table 74. Qiagen N.V. Recent Development Table 75. Promega Company Information Table 76. Promega Business Overview Table 77. Promega mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Promega mRNA Raw Enzyme Product Portfolio Table 79. Promega Recent Development Table 80. Novoprotein Company Information Table 81. Novoprotein Business Overview Table 82. Novoprotein mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Novoprotein mRNA Raw Enzyme Product Portfolio Table 84. Novoprotein Recent Development Table 85. Alphazyme Company Information Table 86. Alphazyme Business Overview Table 87. Alphazyme mRNA Raw Enzyme Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Alphazyme mRNA Raw Enzyme Product Portfolio Table 89. Alphazyme Recent Development Table 90. LGC Biosearch Technologies Company Information Table 91. LGC Biosearch Technologies Business Overview Table 92. LGC Biosearch Technologies mRNA Raw Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. LGC Biosearch Technologies mRNA Raw Enzyme Product Portfolio Table 94. LGC Biosearch Technologies Recent Development Table 95. Jena Bioscience Company Information Table 96. Jena Bioscience Business Overview Table 97. Jena Bioscience mRNA Raw Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Jena Bioscience mRNA Raw Enzyme Product Portfolio Table 99. Jena Bioscience Recent Development Table 100. Yeasen Biotechnology Company Information Table 101. Yeasen Biotechnology Business Overview Table 102. Yeasen Biotechnology mRNA Raw Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Yeasen Biotechnology mRNA Raw Enzyme Product Portfolio Table 104. Yeasen Biotechnology Recent Development Table 105. Hongene Biotech Company Information Table 106. Hongene Biotech Business Overview Table 107. Hongene Biotech mRNA Raw Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Hongene Biotech mRNA Raw Enzyme Product Portfolio Table 109. Hongene Biotech Recent Development Table 110. Enzo Biochem Company Information Table 111. Enzo Biochem Business Overview Table 112. Enzo Biochem mRNA Raw Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Enzo Biochem mRNA Raw Enzyme Product Portfolio Table 114. Enzo Biochem Recent Development Table 115. Spindle (Applied DNA Sciences) Company Information Table 116. Spindle (Applied DNA Sciences) Business Overview Table 117. Spindle (Applied DNA Sciences) mRNA Raw Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Spindle (Applied DNA Sciences) mRNA Raw Enzyme Product Portfolio Table 119. Spindle (Applied DNA Sciences) Recent Development Table 120. Vazyme Company Information Table 121. Vazyme Business Overview Table 122. Vazyme mRNA Raw Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Vazyme mRNA Raw Enzyme Product Portfolio Table 124. Vazyme Recent Development Table 125. North America mRNA Raw Enzyme Revenue by Type (2021-2026) & (US$ Million) Table 126. North America mRNA Raw Enzyme Revenue by Type (2027-2032) & (US$ Million) Table 127. North America mRNA Raw Enzyme Revenue by Application (2021-2026) & (US$ Million) Table 128. North America mRNA Raw Enzyme Revenue by Application (2027-2032) & (US$ Million) Table 129. North America mRNA Raw Enzyme Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America mRNA Raw Enzyme Revenue by Country (2021-2026) & (US$ Million) Table 131. North America mRNA Raw Enzyme Revenue by Country (US$ Million) & (2027-2032) Table 132. Europe mRNA Raw Enzyme Revenue by Type (2021-2026) & (US$ Million) Table 133. Europe mRNA Raw Enzyme Revenue by Type (2027-2032) & (US$ Million) Table 134. Europe mRNA Raw Enzyme Revenue by Application (2021-2026) & (US$ Million) Table 135. Europe mRNA Raw Enzyme Revenue by Application (2027-2032) & (US$ Million) Table 136. Europe mRNA Raw Enzyme Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe mRNA Raw Enzyme Revenue by Country (2021-2026) & (US$ Million) Table 138. Europe mRNA Raw Enzyme Revenue by Country (US$ Million) & (2027-2032) Table 139. China mRNA Raw Enzyme Revenue by Type (2021-2026) & (US$ Million) Table 140. China mRNA Raw Enzyme Revenue by Type (2027-2032) & (US$ Million) Table 141. China mRNA Raw Enzyme Revenue by Application (2021-2026) & (US$ Million) Table 142. China mRNA Raw Enzyme Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia mRNA Raw Enzyme Revenue by Type (2021-2026) & (US$ Million) Table 144. Asia mRNA Raw Enzyme Revenue by Type (2027-2032) & (US$ Million) Table 145. Asia mRNA Raw Enzyme Revenue by Application (2021-2026) & (US$ Million) Table 146. Asia mRNA Raw Enzyme Revenue by Application (2027-2032) & (US$ Million) Table 147. Asia mRNA Raw Enzyme Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Asia mRNA Raw Enzyme Revenue by Region (US$ Million) & (2021-2026) Table 149. Asia mRNA Raw Enzyme Revenue by Region (US$ Million) & (2027-2032) Table 150. SAMEA mRNA Raw Enzyme Revenue by Type (2021-2026) & (US$ Million) Table 151. SAMEA mRNA Raw Enzyme Revenue by Type (2027-2032) & (US$ Million) Table 152. SAMEA mRNA Raw Enzyme Revenue by Application (2021-2026) & (US$ Million) Table 153. SAMEA mRNA Raw Enzyme Revenue by Application (2027-2032) & (US$ Million) Table 154. SAMEA mRNA Raw Enzyme Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. SAMEA mRNA Raw Enzyme Revenue by Country (2021-2026) & (US$ Million) Table 156. SAMEA mRNA Raw Enzyme Revenue by Country (US$ Million) & (2027-2032) Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. mRNA Raw Enzyme Image Figure 2. Global mRNA Raw Enzyme Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global mRNA Raw Enzyme Market Size Share 2021 VS 2025 VS 2032 Figure 4. Restriction Enzyme Image Figure 5. RNA Polymerase Image Figure 6. Capping Enzyme Image Figure 7. Inorganic Pyrophosphatase Image Figure 8. RNase Inhibitor Image Figure 9. 2'-O-Methyltransferase Image Figure 10. Poly(A) Polymerase Image Figure 11. DNase I Image Figure 12. Global mRNA Raw Enzyme Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global mRNA Raw Enzyme Market Size Share 2021 VS 2025 VS 2032 Figure 14. Biopharmaceutical Companies Image Figure 15. Academic and Research Institutes Image Figure 16. Global mRNA Raw Enzyme Market Size (US$ Million) & (2021-2032) Figure 17. Global mRNA Raw Enzyme Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global mRNA Raw Enzyme Market Share by Region: 2021 VS 2025 VS 2032 Figure 19. Global mRNA Raw Enzyme Players Revenue Share Top 10 and Top 5 in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global mRNA Raw Enzyme Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global mRNA Raw Enzyme Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global mRNA Raw Enzyme Revenue Market Share by Type (2021-2032) Figure 24. Global mRNA Raw Enzyme Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global mRNA Raw Enzyme Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 26. Global mRNA Raw Enzyme Revenue Market Share by Application (2021-2032) Figure 27. North America mRNA Raw Enzyme Revenue YoY Growth (2021-2032) & (US$ Million) Figure 28. North America mRNA Raw Enzyme Revenue Share by Type (2021-2032) Figure 29. North America mRNA Raw Enzyme Revenue Share by Application (2021-2032) Figure 30. North America mRNA Raw Enzyme Revenue Share by Country (2021-2032) Figure 31. United States mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Canada mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Mexico mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Europe mRNA Raw Enzyme Revenue YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe mRNA Raw Enzyme Revenue Share by Type (2021-2032) Figure 36. Europe mRNA Raw Enzyme Revenue Share by Application (2021-2032) Figure 37. Europe mRNA Raw Enzyme Revenue Share by Country (2021-2032) Figure 38. Germany mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. France mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. U.K. mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Italy mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Spain mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Russia mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Netherlands mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Nordic Countries mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. China mRNA Raw Enzyme Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. China mRNA Raw Enzyme Revenue Share by Type (2021-2032) Figure 48. China mRNA Raw Enzyme Revenue Share by Application (2021-2032) Figure 49. Asia mRNA Raw Enzyme Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. Asia mRNA Raw Enzyme Revenue Share by Type (2021-2032) Figure 51. Asia mRNA Raw Enzyme Revenue Share by Application (2021-2032) Figure 52. Asia mRNA Raw Enzyme Revenue Share by Region (2021-2032) Figure 53. Japan mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. South Korea mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. India mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Australia mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Taiwan mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Southeast Asia mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. SAMEA mRNA Raw Enzyme Revenue YoY Growth (2021-2032) & (US$ Million) Figure 60. SAMEA mRNA Raw Enzyme Revenue Share by Type (2021-2032) Figure 61. SAMEA mRNA Raw Enzyme Revenue Share by Application (2021-2032) Figure 62. SAMEA mRNA Raw Enzyme Revenue Share by Country (2021-2032) Figure 63. Brazil mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Argentina mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Chile mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Colombia mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Peru mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Saudi Arabia mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Israel mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. UAE mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Turkey mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Iran mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Egypt mRNA Raw Enzyme Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Restriction Enzyme
  • RNA Polymerase
  • Capping Enzyme
  • Inorganic Pyrophosphatase
  • RNase Inhibitor
  • 2'-O-Methyltransferase
  • Poly(A) Polymerase
  • DNase I
Applications
  • Biopharmaceutical Companies
  • Academic and Research Institutes
Companies covered
  • Thermo Fisher
  • NEB
  • Merck
  • Aldevron
  • Roche CustomBiotech
  • Takara Bio Inc.
  • Qiagen N.V.
  • Promega
  • Novoprotein
  • Alphazyme
  • LGC Biosearch Technologies
  • Jena Bioscience
  • Yeasen Biotechnology
  • Hongene Biotech
  • Enzo Biochem
  • Spindle (Applied DNA Sciences)
  • Vazyme

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 mRNA Raw Enzyme Market by Type
  3. 1.2.1 Global mRNA Raw Enzyme Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Restriction Enzyme
  5. 1.2.3 RNA Polymerase
  6. 1.2.4 Capping Enzyme
  7. 1.2.5 Inorganic Pyrophosphatase
  8. 1.2.6 RNase Inhibitor
  9. 1.2.7 2'-O-Methyltransferase
  10. 1.2.8 Poly(A) Polymerase
  11. 1.2.9 DNase I
  12. 1.3 mRNA Raw Enzyme Market by Application
  13. 1.3.1 Global mRNA Raw Enzyme Market Size by Application, 2021 VS 2025 VS 2032
  14. 1.3.2 Biopharmaceutical Companies
  15. 1.3.3 Academic and Research Institutes
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 mRNA Raw Enzyme Market Dynamics
  1. 2.1 mRNA Raw Enzyme Industry Trends
  2. 2.2 mRNA Raw Enzyme Industry Drivers
  3. 2.3 mRNA Raw Enzyme Industry Opportunities and Challenges
  4. 2.4 mRNA Raw Enzyme Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global mRNA Raw Enzyme Market Perspective (2021-2032)
  2. 3.2 Global mRNA Raw Enzyme Growth Trends by Region
  3. 3.2.1 Global mRNA Raw Enzyme Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global mRNA Raw Enzyme Market Size by Region (2021-2026)
  5. 3.2.3 Global mRNA Raw Enzyme Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global mRNA Raw Enzyme Revenue by Players
  2. 4.1.1 Global mRNA Raw Enzyme Revenue by Players (2021-2026)
  3. 4.1.2 Global mRNA Raw Enzyme Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global mRNA Raw Enzyme Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global mRNA Raw Enzyme Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global mRNA Raw Enzyme Key Players Headquarters & Area Served
  7. 4.4 Global mRNA Raw Enzyme Players, Product Type & Application
  8. 4.5 Global mRNA Raw Enzyme Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global mRNA Raw Enzyme Market CR5 and HHI
  11. 4.6.3 2025 mRNA Raw Enzyme Tier 1, Tier 2, and Tier 3
5 mRNA Raw Enzyme Market Size by Type
  1. 5.1 Global mRNA Raw Enzyme Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global mRNA Raw Enzyme Revenue by Type (2021-2032)
  3. 5.3 Global mRNA Raw Enzyme Revenue Market Share by Type (2021-2032)
6 mRNA Raw Enzyme Market Size by Application
  1. 6.1 Global mRNA Raw Enzyme Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global mRNA Raw Enzyme Revenue by Application (2021-2032)
  3. 6.3 Global mRNA Raw Enzyme Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Thermo Fisher
  2. 7.1.1 Thermo Fisher Company Information
  3. 7.1.2 Thermo Fisher Business Overview
  4. 7.1.3 Thermo Fisher mRNA Raw Enzyme Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Thermo Fisher mRNA Raw Enzyme Product Portfolio
  6. 7.1.5 Thermo Fisher Recent Developments
  7. 7.2 NEB
  8. 7.2.1 NEB Company Information
  9. 7.2.2 NEB Business Overview
  10. 7.2.3 NEB mRNA Raw Enzyme Revenue and Gross Margin (2021-2026)
  11. 7.2.4 NEB mRNA Raw Enzyme Product Portfolio
  12. 7.2.5 NEB Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck mRNA Raw Enzyme Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Merck mRNA Raw Enzyme Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Aldevron
  20. 7.4.1 Aldevron Company Information
  21. 7.4.2 Aldevron Business Overview
  22. 7.4.3 Aldevron mRNA Raw Enzyme Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Aldevron mRNA Raw Enzyme Product Portfolio
  24. 7.4.5 Aldevron Recent Developments
  25. 7.5 Roche CustomBiotech
  26. 7.5.1 Roche CustomBiotech Company Information
  27. 7.5.2 Roche CustomBiotech Business Overview
  28. 7.5.3 Roche CustomBiotech mRNA Raw Enzyme Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Roche CustomBiotech mRNA Raw Enzyme Product Portfolio
  30. 7.5.5 Roche CustomBiotech Recent Developments
  31. 7.6 Takara Bio Inc.
  32. 7.6.1 Takara Bio Inc. Company Information
  33. 7.6.2 Takara Bio Inc. Business Overview
  34. 7.6.3 Takara Bio Inc. mRNA Raw Enzyme Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Takara Bio Inc. mRNA Raw Enzyme Product Portfolio
  36. 7.6.5 Takara Bio Inc. Recent Developments
  37. 7.7 Qiagen N.V.
  38. 7.7.1 Qiagen N.V. Company Information
  39. 7.7.2 Qiagen N.V. Business Overview
  40. 7.7.3 Qiagen N.V. mRNA Raw Enzyme Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Qiagen N.V. mRNA Raw Enzyme Product Portfolio
  42. 7.7.5 Qiagen N.V. Recent Developments
  43. 7.8 Promega
  44. 7.8.1 Promega Company Information
  45. 7.8.2 Promega Business Overview
  46. 7.8.3 Promega mRNA Raw Enzyme Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Promega mRNA Raw Enzyme Product Portfolio
  48. 7.8.5 Promega Recent Developments
  49. 7.9 Novoprotein
  50. 7.9.1 Novoprotein Company Information
  51. 7.9.2 Novoprotein Business Overview
  52. 7.9.3 Novoprotein mRNA Raw Enzyme Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Novoprotein mRNA Raw Enzyme Product Portfolio
  54. 7.9.5 Novoprotein Recent Developments
  55. 7.10 Alphazyme
  56. 7.10.1 Alphazyme Company Information
  57. 7.10.2 Alphazyme Business Overview
  58. 7.10.3 Alphazyme mRNA Raw Enzyme Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Alphazyme mRNA Raw Enzyme Product Portfolio
  60. 7.10.5 Alphazyme Recent Developments
  61. 7.11 LGC Biosearch Technologies
  62. 7.11.1 LGC Biosearch Technologies Company Information
  63. 7.11.2 LGC Biosearch Technologies Business Overview
  64. 7.11.3 LGC Biosearch Technologies mRNA Raw Enzyme Revenue and Gross Margin (2021-2026)
  65. 7.11.4 LGC Biosearch Technologies mRNA Raw Enzyme Product Portfolio
  66. 7.11.5 LGC Biosearch Technologies Recent Developments
  67. 7.12 Jena Bioscience
  68. 7.12.1 Jena Bioscience Company Information
  69. 7.12.2 Jena Bioscience Business Overview
  70. 7.12.3 Jena Bioscience mRNA Raw Enzyme Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Jena Bioscience mRNA Raw Enzyme Product Portfolio
  72. 7.12.5 Jena Bioscience Recent Developments
  73. 7.13 Yeasen Biotechnology
  74. 7.13.1 Yeasen Biotechnology Company Information
  75. 7.13.2 Yeasen Biotechnology Business Overview
  76. 7.13.3 Yeasen Biotechnology mRNA Raw Enzyme Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Yeasen Biotechnology mRNA Raw Enzyme Product Portfolio
  78. 7.13.5 Yeasen Biotechnology Recent Developments
  79. 7.14 Hongene Biotech
  80. 7.14.1 Hongene Biotech Company Information
  81. 7.14.2 Hongene Biotech Business Overview
  82. 7.14.3 Hongene Biotech mRNA Raw Enzyme Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Hongene Biotech mRNA Raw Enzyme Product Portfolio
  84. 7.14.5 Hongene Biotech Recent Developments
  85. 7.15 Enzo Biochem
  86. 7.15.1 Enzo Biochem Company Information
  87. 7.15.2 Enzo Biochem Business Overview
  88. 7.15.3 Enzo Biochem mRNA Raw Enzyme Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Enzo Biochem mRNA Raw Enzyme Product Portfolio
  90. 7.15.5 Enzo Biochem Recent Developments
  91. 7.16 Spindle (Applied DNA Sciences)
  92. 7.16.1 Spindle (Applied DNA Sciences) Company Information
  93. 7.16.2 Spindle (Applied DNA Sciences) Business Overview
  94. 7.16.3 Spindle (Applied DNA Sciences) mRNA Raw Enzyme Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Spindle (Applied DNA Sciences) mRNA Raw Enzyme Product Portfolio
  96. 7.16.5 Spindle (Applied DNA Sciences) Recent Developments
  97. 7.17 Vazyme
  98. 7.17.1 Vazyme Company Information
  99. 7.17.2 Vazyme Business Overview
  100. 7.17.3 Vazyme mRNA Raw Enzyme Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Vazyme mRNA Raw Enzyme Product Portfolio
  102. 7.17.5 Vazyme Recent Developments
8 North America
  1. 8.1 North America mRNA Raw Enzyme Revenue (2021-2032)
  2. 8.2 North America mRNA Raw Enzyme Revenue by Type (2021-2032)
  3. 8.2.1 North America mRNA Raw Enzyme Revenue by Type (2021-2026)
  4. 8.2.2 North America mRNA Raw Enzyme Revenue by Type (2027-2032)
  5. 8.3 North America mRNA Raw Enzyme Revenue Share by Type (2021-2032)
  6. 8.4 North America mRNA Raw Enzyme Revenue by Application (2021-2032)
  7. 8.4.1 North America mRNA Raw Enzyme Revenue by Application (2021-2026)
  8. 8.4.2 North America mRNA Raw Enzyme Revenue by Application (2027-2032)
  9. 8.5 North America mRNA Raw Enzyme Revenue Share by Application (2021-2032)
  10. 8.6 North America mRNA Raw Enzyme Revenue by Country
  11. 8.6.1 North America mRNA Raw Enzyme Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America mRNA Raw Enzyme Revenue by Country (2021-2026)
  13. 8.6.3 North America mRNA Raw Enzyme Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe mRNA Raw Enzyme Revenue (2021-2032)
  2. 9.2 Europe mRNA Raw Enzyme Revenue by Type (2021-2032)
  3. 9.2.1 Europe mRNA Raw Enzyme Revenue by Type (2021-2026)
  4. 9.2.2 Europe mRNA Raw Enzyme Revenue by Type (2027-2032)
  5. 9.3 Europe mRNA Raw Enzyme Revenue Share by Type (2021-2032)
  6. 9.4 Europe mRNA Raw Enzyme Revenue by Application (2021-2032)
  7. 9.4.1 Europe mRNA Raw Enzyme Revenue by Application (2021-2026)
  8. 9.4.2 Europe mRNA Raw Enzyme Revenue by Application (2027-2032)
  9. 9.5 Europe mRNA Raw Enzyme Revenue Share by Application (2021-2032)
  10. 9.6 Europe mRNA Raw Enzyme Revenue by Country
  11. 9.6.1 Europe mRNA Raw Enzyme Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe mRNA Raw Enzyme Revenue by Country (2021-2026)
  13. 9.6.3 Europe mRNA Raw Enzyme Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China mRNA Raw Enzyme Revenue (2021-2032)
  2. 10.2 China mRNA Raw Enzyme Revenue by Type (2021-2032)
  3. 10.2.1 China mRNA Raw Enzyme Revenue by Type (2021-2026)
  4. 10.2.2 China mRNA Raw Enzyme Revenue by Type (2027-2032)
  5. 10.3 China mRNA Raw Enzyme Revenue Share by Type (2021-2032)
  6. 10.4 China mRNA Raw Enzyme Revenue by Application (2021-2032)
  7. 10.4.1 China mRNA Raw Enzyme Revenue by Application (2021-2026)
  8. 10.4.2 China mRNA Raw Enzyme Revenue by Application (2027-2032)
  9. 10.5 China mRNA Raw Enzyme Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia mRNA Raw Enzyme Revenue (2021-2032)
  2. 11.2 Asia mRNA Raw Enzyme Revenue by Type (2021-2032)
  3. 11.2.1 Asia mRNA Raw Enzyme Revenue by Type (2021-2026)
  4. 11.2.2 Asia mRNA Raw Enzyme Revenue by Type (2027-2032)
  5. 11.3 Asia mRNA Raw Enzyme Revenue Share by Type (2021-2032)
  6. 11.4 Asia mRNA Raw Enzyme Revenue by Application (2021-2032)
  7. 11.4.1 Asia mRNA Raw Enzyme Revenue by Application (2021-2026)
  8. 11.4.2 Asia mRNA Raw Enzyme Revenue by Application (2027-2032)
  9. 11.5 Asia mRNA Raw Enzyme Revenue Share by Application (2021-2032)
  10. 11.6 Asia mRNA Raw Enzyme Revenue by Country
  11. 11.6.1 Asia mRNA Raw Enzyme Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia mRNA Raw Enzyme Revenue by Country (2021-2026)
  13. 11.6.3 Asia mRNA Raw Enzyme Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA mRNA Raw Enzyme Revenue (2021-2032)
  2. 12.2 SAMEA mRNA Raw Enzyme Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA mRNA Raw Enzyme Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA mRNA Raw Enzyme Revenue by Type (2027-2032)
  5. 12.3 SAMEA mRNA Raw Enzyme Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA mRNA Raw Enzyme Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA mRNA Raw Enzyme Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA mRNA Raw Enzyme Revenue by Application (2027-2032)
  9. 12.5 SAMEA mRNA Raw Enzyme Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA mRNA Raw Enzyme Revenue by Country
  11. 12.6.1 SAMEA mRNA Raw Enzyme Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA mRNA Raw Enzyme Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA mRNA Raw Enzyme Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst